Sudeep Pharma · NSE: SUDEEPPHRM · BSE: 544619

Q4 FY26 results · Jan–Mar 2026

Sudeep Pharma reported revenue from operations of ₹182.34 crore and net profit of ₹48.54 crore for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.

Consolidated · ₹ crore
Item	Q4 FY26	Q4 FY25	YoY	Q3 FY26	QoQ
Revenue from operations	182.34	—	—	172.34	+5.8%
Other income	6.42	—	—	6.84	−6.0%
Total income	188.76	—	—	179.17	+5.4%
Profit before tax	62.69	—	—	61.78	+1.5%
Net profit for the period	48.54	—	—	47.70	+1.8%
Attributable to shareholders of the company	48.88	—	—	(2.03)	Turned profit
EPS, basic (₹)	4.38	—	—	4.29	+2.1%
Net margin (%)	26.6	—		27.7

Standalone · ₹ crore
Item	Q4 FY26	Q4 FY25	YoY	Q3 FY26	QoQ
Revenue from operations	80.17	—	—	90.28	−11.2%
Other income	9.62	—	—	9.44	+1.9%
Total income	89.79	—	—	99.72	−10.0%
Profit before tax	34.74	—	—	36.62	−5.1%
Net profit for the period	25.77	—	—	26.87	−4.1%
EPS, basic (₹)	2.31	—	—	2.42	−4.5%
Net margin (%)	32.1	—		29.8

Consolidated

Standalone